{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:39:57Z","timestamp":1783085997452,"version":"3.54.6"},"reference-count":160,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T00:00:00Z","timestamp":1560988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01407","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T13:54:08Z","timestamp":1561038848000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Coagulation and Skin Autoimmunity"],"prefix":"10.3389","volume":"10","author":[{"given":"Massimo","family":"Cugno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Garcovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Valerio","family":"Marzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1097\/00003246-200009001-00017","article-title":"Phylogenetic and functional relationships between coagulation and the innate immune response","volume":"28","author":"Opal","year":"2000","journal-title":"Crit Care Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.maturitas.2008.11.008","article-title":"Crosstalk between inflammation and thrombosis","volume":"61","author":"Esmon","year":"2008","journal-title":"Maturitas"},{"key":"B3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.tcm.2005.07.004","article-title":"Two-way interactions between inflammation and coagulation","volume":"15","author":"Levi","year":"2005","journal-title":"Trends Cardiovasc Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.abb.2005.06.005","article-title":"Tissue factor mediates inflammation","volume":"440","author":"Chu","year":"2005","journal-title":"Arch Biochem Biophys"},{"key":"B5","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1177\/0961203308097566","article-title":"Thrombophilic patterns of coagulation factors in lupus","volume":"18","author":"Dhar","year":"2009","journal-title":"Lupus"},{"key":"B6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1556\/2060.104.2017.1.5","article-title":"Characterization of the thrombin generation profile in systemic lupus erythematosus","volume":"104","author":"Kern","year":"2017","journal-title":"Physiol Int"},{"key":"B7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jaut.2008.07.002","article-title":"Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade","volume":"31","author":"Ingegnoli","year":"2008","journal-title":"J Autoimmun"},{"key":"B8","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s00296-018-4001-9","article-title":"From blood coagulation to innate and adaptive immunity: the role of platelets in the physiology and pathology of autoimmune disorders","volume":"38","author":"\u0141ukasik","year":"2018","journal-title":"Rheumatol Int"},{"key":"B9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.tips.2008.10.007","article-title":"Coagulation factor Xa signaling: the link between coagulation and inflammatory bowel disease?","volume":"30","author":"Borensztajn","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.3748\/wjg.v20.i17.4857","article-title":"Venous thrombosis and prothrombotic factors in inflammatory bowel disease","volume":"20","author":"Magro","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/all.12313","article-title":"The EAACI\/GA2LEN\/EDF\/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update","volume":"69","author":"Zuberbier","year":"2014","journal-title":"Allergy"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.iac.2013.07.009","article-title":"Pathology and classification of urticaria","volume":"34","author":"Greaves","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"B13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.iac.2013.09.012","article-title":"Chronic spontaneous urticaria: etiology and pathogenesis","volume":"34","author":"Saini","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1111\/j.1365-2222.2005.02380.x","article-title":"In chronic idiopathic urticaria autoantibodies against Fc epsilonRII\/CD23 induce histamine release via eosinophil activation","volume":"35","author":"Puccetti","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e0145751","DOI":"10.1371\/journal.pone.0145751","article-title":"IL-6 transsignaling in patients with chronic spontaneous urticaria","volume":"10","author":"Kasperska-Zajac","year":"2015","journal-title":"PLoS ONE"},{"key":"B16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2340\/00015555-1443","article-title":"Co-existence of chronic urticaria and metabolic syndrome: clinical implications","volume":"93","author":"Ye","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/all.13352","article-title":"C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria","volume":"73","author":"Kolkhir","year":"2018","journal-title":"Allergy"},{"key":"B18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000452626","article-title":"Altered systemic adipokines in patients with chronic urticaria","volume":"171","author":"Trinh","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11739-009-0333-5","article-title":"Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications","volume":"5","author":"Cugno","year":"2010","journal-title":"Intern Emerg Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1111\/all.13587","article-title":"Elevated IgE to tissue factor and thyroglobulin are abated by omalizumab in chronic spontaneous urticaria","volume":"73","author":"Cugno","year":"2018","journal-title":"Allergy"},{"key":"B21","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000350388","article-title":"Significantly high levels of anti-dsDNA immunoglobulin E in sera and the ability of dsDNA to induce the degranulation of basophils from chronic urticaria patients","volume":"161","author":"Hatada","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e14794","DOI":"10.1371\/journal.pone.0014794","article-title":"IgE mediated autoallergy against thyroid peroxidase\u2013a novel pathomechanism of chronic spontaneous urticaria?","volume":"6","author":"Altrichter","year":"2011","journal-title":"PLoS ONE"},{"key":"B23","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.jaci.2017.10.035","article-title":"IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria","volume":"142","author":"Schmetzer","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/all.12389","article-title":"Chronic urticaria and coagulation: pathophysiological and clinical aspects","volume":"69","author":"Tedeschi","year":"2014","journal-title":"Allergy"},{"key":"B25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3109\/08916930903293086","article-title":"Skin autoimmunity and blood coagulation","volume":"43","author":"Cugno","year":"2010","journal-title":"Autoimmunity"},{"key":"B26","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1046\/j.1365-2133.1999.02815.x","article-title":"Human leucocyte antigen class II associations in chronic idiopathic urticaria","volume":"140","author":"O'Donnell","year":"1999","journal-title":"Br J Dermatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1365-2222.2005.02168.x","article-title":"Increased plasma levels of matrix metalloproteinase-9 are associated with the severity of chronic urticaria","volume":"35","author":"Kessel","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.12688\/f1000research.11546.1","article-title":"Chronic urticaria: a focus on pathogenesis","volume":"6","author":"Asero","year":"2017","journal-title":"F1000Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jaci.2005.12.1343","article-title":"Plasma of chronic urticaria patients shows signs of thrombin generation and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum","volume":"117","author":"Asero","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jaci.2006.08.043","article-title":"Activation of the tissue pathway of blood coagulation in patients with chronic urticaria","volume":"119","author":"Asero","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1398-9995.2007.01514.x","article-title":"Severe chronic urticaria is associated with elevated plasma levels of D-dimer","volume":"63","author":"Asero","year":"2008","journal-title":"Allergy"},{"key":"B32","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000155748","article-title":"Expression of tissue factor by eosinophils in patients with chronic urticaria","volume":"148","author":"Cugno","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1398-9995.2010.02506.x","article-title":"Increase of coagulation potential in chronic spontaneous urticaria","volume":"66","author":"Takeda","year":"2011","journal-title":"Allergy"},{"key":"B34","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1182\/blood-2006-02-004945","article-title":"Eosinophils are a major intravascular location for tissue factor storage and exposure","volume":"109","author":"Moosbauer","year":"2007","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1152\/ajpheart.1993.264.6.H1798","article-title":"Thrombin and bradykinin initiate discrete endothelial solute permeability mechanisms","volume":"264","author":"Schaeffer","year":"1993","journal-title":"Am J Physiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.autrev.2007.08.002","article-title":"Chronic urticaria: a disease at a crossroad between autoimmunity and coagulation","volume":"7","author":"Asero","year":"2007","journal-title":"Autoimmun Rev"},{"key":"B37","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nm1419","article-title":"Generation of C5a in the absence of C3: a new complement activation pathway","volume":"12","author":"Huber-Lang","year":"2006","journal-title":"Nat Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.4049\/jimmunol.169.8.4551","article-title":"Thrombin induces mast cell adhesion to fibronectin: evidence for the involvement of protease activated receptor-1","volume":"169","author":"Vliagoftis","year":"2002","journal-title":"J Immunol"},{"key":"B39","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.4049\/jimmunol.133.6.3282","article-title":"Thrombin-induced degranulation of cultured bone marrow derived mast cells","volume":"133","author":"Razin","year":"1984","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0014-2999(03)01752-7","article-title":"Activation of mast cells induced by agonists of proteinase-activated receptors under normal conditions and during acute inflammation in rats","volume":"471","author":"Dugina","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.alit.2017.09.003","article-title":"Chronic spontaneous urticaria and the extrinsic coagulation system","volume":"67","author":"Yanase","year":"2018","journal-title":"Allergol Int"},{"key":"B42","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1084\/jem.183.3.821","article-title":"Thrombin functions as an inflammatory mediator through activation of its receptors","volume":"183","author":"Cirino","year":"1996","journal-title":"J Exp Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/j.1365-2222.2010.03473.x","article-title":"Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors","volume":"40","author":"Tedeschi","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"B44","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/QCO.0b013e328344c078","article-title":"The effect of inflammation on coagulation and vice versa","volume":"24","author":"van der Poll","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0006-291X(85)91177-5","article-title":"Tryptase from rat mast cells converts bovine prothrombin to thrombin","volume":"132","author":"Kido","year":"1985","journal-title":"Biochem Biophys Res Commun"},{"key":"B46","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/exd.13407","article-title":"Mast cells are critical for the limitation of thrombin-induced skin inflammation","volume":"27","author":"Suender","year":"2018","journal-title":"Exp Dermatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.jaci.2009.01.039","article-title":"Activation of the blood coagulation cascade is involved in patients with chronic urticaria","volume":"123","author":"Wang","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1346-8138.2008.00474.x","article-title":"Elevation of circulating thrombin-antithrombin III complex and fibrin degradation products in urticaria","volume":"35","author":"Fujii","year":"2008","journal-title":"J Dermatol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e0129456","DOI":"10.1371\/journal.pone.0129456","article-title":"Activation of blood coagulation in two prototypic autoimmune skin diseases: a possible link with thrombotic risk","volume":"10","author":"Cugno","year":"2015","journal-title":"PLoS ONE"},{"key":"B50","doi-asserted-by":"publisher","first-page":"100","DOI":"10.5415\/apallergy.2013.3.2.100","article-title":"Correlation between plasma D-dimer levels and the severity of patients with chronic urticaria","volume":"3","author":"Triwongwaranat","year":"2013","journal-title":"Asia Pac Allergy"},{"key":"B51","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1590\/abd1806-4841.20131532","article-title":"Evaluation of D-dimer serum levels among patients with chronic urticaria, psoriasis and urticarial vasculitis","volume":"88","author":"Criado","year":"2013","journal-title":"An Bras Dermatol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"649e56","DOI":"10.1111\/j.1398-9995.2009.02222.x","article-title":"Coagulation\/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria","volume":"65","author":"Takahagi","year":"2010","journal-title":"Allergy"},{"key":"B53","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13223-018-0255-8","article-title":"Interplay between acute phase response and coagulation\/fibrinolysis in chronic spontaneous urticaria","volume":"18","author":"Grzanka","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1468-3083.2007.02511.x","article-title":"Efficacy and safety of desloratadine combined with dipyridamole in the treatment of chronic urticaria","volume":"22","author":"Khalaf","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2174\/157016112801784558","article-title":"Inflammation and coagulation in urticaria and angioedema","volume":"10","author":"Cugno","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000444085","article-title":"The role of platelets in chronic urticaria","volume":"169","author":"Vena","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/09537100802082249","article-title":"Platelet function in cutaneous diseases","volume":"19","author":"Kasperska-Zajac","year":"2008","journal-title":"Platelets"},{"key":"B58","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jaad.2009.06.053","article-title":"Platelet activation in patients with psoriasis: increased plasma levels of platelet-derived microparticles and soluble P-selectin","volume":"62","author":"Tamagawa-Mineoka","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.thromres.2012.11.028","article-title":"Platelet-leukocyte crosstalk: linking proinflammatory responses to procoagulant state","volume":"131","author":"Ghasemzadeh","year":"2013","journal-title":"Thromb Res"},{"key":"B60","first-page":"286","article-title":"Treatment of chronic urticaria with heparin","volume":"59","author":"Meyer-De Schmid","year":"1952","journal-title":"Bull Soc Fr Dermatol Syphiligr"},{"key":"B61","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/j.1365-2133.2005.06694.x","article-title":"Chronic urticaria responding to subcutaneous heparin sodium","volume":"153","author":"Chua","year":"2005","journal-title":"Br J Dermatol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1159\/000292947","article-title":"Heparin and tranexamic Acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot study","volume":"152","author":"Asero","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1046\/j.1365-2222.2000.00857.x","article-title":"Warfarin treatment of chronic idiopathic urticaria and angio-oedema","volume":"30","author":"Parslew","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"B64","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.jaci.2013.04.037","article-title":"D-dimer: a biomarker for antihistamine-resistant chronic urticaria","volume":"132","author":"Asero","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.jaci.2014.11.016","article-title":"Plasma D-dimer levels and clinical response to ciclosporin in severe chronic spontaneous urticaria","volume":"135","author":"Asero","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/bjd.16593","article-title":"IgE and D-dimer baseline levels are higher in responders than nonresponders to omalizumab in chronic spontaneous urticaria","volume":"179","author":"Cugno","year":"2018","journal-title":"Br J Dermatol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000453453","article-title":"D-dimer plasma levels parallel the clinical response to omalizumab in patients with severe chronic spontaneous urticaria","volume":"172","author":"Asero","year":"2017","journal-title":"Int Arch Allergy Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15569527.2018.1495227","article-title":"The effect of omalizumab on hematological and inflammatory parameters in patients with chronic spontaneous urticaria","volume":"10","author":"Acer","year":"2018","journal-title":"Cutan Ocul Toxicol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/all.13083","article-title":"Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria","volume":"72","author":"Kaplan","year":"2017","journal-title":"Allergy"},{"key":"B70","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejim.2018.09.004","article-title":"Angioedema and emergency medicine: from pathophysiology to diagnosis and treatment","volume":"59","author":"Depetri","year":"2019","journal-title":"Eur J Intern Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jaad.2018.01.020","article-title":"Urticaria: a comprehensive review: epidemiology, diagnosis, and work-up","volume":"79","author":"Antia","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/jid.2014.16","article-title":"Basophils and skin disorders","volume":"134","author":"Borriello","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s12016-016-8540-0","article-title":"Bradykinin: inflammatory product of the coagulation system","volume":"51","author":"Hofman","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1160\/TH06-03-0128","article-title":"Plasma levels of bradykinin are suppressed in factor XII-deficient mice","volume":"95","author":"Iwaki","year":"2006","journal-title":"Thromb Haemost"},{"key":"B75","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jaci.2013.03.026","article-title":"Factor XII-independent activation of the bradykininforming cascade: Implications for the pathogenesis of hereditary angioedema types I and II","volume":"132","author":"Joseph","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","article-title":"Plasma bradykinin in angio-oedema","volume":"351","author":"Nussberger","year":"1998","journal-title":"Lancet"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S0091-6749(99)70030-8","article-title":"Local bradykinin generation in hereditary angioedema","volume":"104","author":"Nussberger","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.molmed.2008.12.001","article-title":"C1-inhibitor deficiency and angioedema: Molecular mechanisms and clinical progress","volume":"15","author":"Cugno","year":"2009","journal-title":"Trends Mol Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jaip.2013.06.004","article-title":"Hereditary angioedema with normal C1-INH (HAE type III)","volume":"1","author":"Riedl","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1086\/509899","article-title":"Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III","volume":"79","author":"Cichon","year":"2006","journal-title":"Am J Hum Genet"},{"key":"B81","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.autrev.2008.05.003","article-title":"Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation","volume":"8","author":"Cugno","year":"2008","journal-title":"Autoimmun Rev"},{"key":"B82","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1515\/cclm-2015-0195","article-title":"The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity","volume":"54","author":"Wu","year":"2016","journal-title":"Clin Chem Lab Med"},{"key":"B83","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/cea.13326","article-title":"Pharmacogenetics of angiotensin converting enzyme inhibitor - induced angioedema","volume":"49","author":"Liau","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"B84","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJM200208223470820","article-title":"Bradykinin-mediated angioedema","volume":"347","author":"Nussberger","year":"2002","journal-title":"N Engl J Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jaci.2014.07.057","article-title":"Plasma contact system activation drives anaphylaxis in severe mast cell-mediated allergic reactions","volume":"135","author":"Sala-Cunill","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1146\/annurev.iy.06.040188.003115","article-title":"C1 inhibitor and hereditary angioneurotic edema","volume":"6","author":"Davis","year":"1988","journal-title":"Annu Rev Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1515\/cclm.1988.26.7.423","article-title":"Haemostasis contact system and fibrinolysis in hereditary angioedema (C1-inhibitor deficiency)","volume":"26","author":"Cugno","year":"1988","journal-title":"J Clin Chem Clin Biochem"},{"key":"B88","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0162-3109(96)00086-0","article-title":"Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies","volume":"33","author":"Cugno","year":"1996","journal-title":"Immunopharmacology"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1172\/JCI114555","article-title":"Plasma levels of C1-inhibitor complexes and cleaved C1-inhibitor in patients with hereditary angioneurotic edema","volume":"85","author":"Cugno","year":"1990","journal-title":"J Clin Invest"},{"key":"B90","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1182\/blood.V89.9.3213","article-title":"Activation of the coagulation cascade in C1-inhibitor deficiencies","volume":"89","author":"Cugno","year":"1997","journal-title":"Blood"},{"key":"B91","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1398-9995.2008.01859.x","article-title":"Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency","volume":"64","author":"Cugno","year":"2009","journal-title":"Allergy"},{"key":"B92","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/0091-6749(94)90380-8","article-title":"Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid","volume":"93","author":"Cugno","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"B93","first-page":"38","article-title":"Generation of plasmin during acute attacks of hereditary angioedema","volume":"121","author":"Cugno","year":"1993","journal-title":"J Lab Clin Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/(SICI)1097-4652(199606)167:3<562::AID-JCP20>3.0.CO;2-4","article-title":"Mechanisms of a-thrombin, histamine, and bradykinin induced endothelial permeability","volume":"167","author":"Ehringer","year":"1996","journal-title":"J Cell Physiol"},{"key":"B95","first-page":"39","article-title":"Blood coagulation and related plasma enzymes in inflammation","volume":"3","author":"Donaldson","year":"1970","journal-title":"Ser Haemat"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1111\/jth.14209","article-title":"Hereditary angioedema: the plasma contact system out of control","volume":"16","author":"De Maat","year":"2018","journal-title":"J Thromb Haemost"},{"key":"B97","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1182\/blood-2017-04-569111","article-title":"Coagulation factor XII in thrombosis and inflammation","volume":"131","author":"Maas","year":"2018","journal-title":"Blood"},{"key":"B98","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13023-015-0351-5","article-title":"Comprehensive study into the activation of the plasma enzyme systems during attacks of hereditary angioedema due to C1-inhibitor deficiency","volume":"10","author":"Varga","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"B99","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/all.12587","article-title":"Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk","volume":"70","author":"Reshef","year":"2015","journal-title":"Allergy"},{"key":"B100","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/joim.12304","article-title":"Presentation, diagnosis and treatment of angioedema without wheals: a retrospective analysis of a cohort of 1058 patients","volume":"277","author":"Mansi","year":"2015","journal-title":"J Intern Med"},{"key":"B101","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2340\/00015555-2930","article-title":"Mortality in patients with bullous pemphigoid: a retrospective cohort study, systematic review and meta-analysis","volume":"99","author":"Kridin","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00403-018-1875-z","article-title":"Mortality and risk factors among Israeli bullous pemphigoid patients","volume":"311","author":"Rozenblat","year":"2019","journal-title":"Arch Dermatol Res"},{"key":"B103","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/archderm.134.4.465","article-title":"High risk of death in elderly patients with extensive bullous pemphigoid","volume":"134","author":"Roujeau","year":"1998","journal-title":"Arch Dermatol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s40257-017-0264-2","article-title":"Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment","volume":"18","author":"Bernard","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fmed.2018.00220","article-title":"The growing incidence of bullous pemphigoid: overview and potential explanations","volume":"5","author":"Kridin","year":"2018","journal-title":"Front Med."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/j.1365-2133.2012.11108.x","article-title":"Clinical presentation and diagnostic delay in bullous pemphigoid: a prospective nationwide cohort","volume":"167","author":"della Torre","year":"2012","journal-title":"Br J Dermatol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1001\/jama.284.3.350","article-title":"Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations","volume":"284","author":"Yancey","year":"2000","journal-title":"JAMA"},{"key":"B108","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1001\/archdermatol.2009.53","article-title":"Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study","volume":"145","author":"Bernard","year":"2009","journal-title":"Arch Dermatol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1172\/JCI200524855","article-title":"The pathophysiology of autoimmune blistering diseases","volume":"115","author":"Yancey","year":"2005","journal-title":"J Clin Invest"},{"key":"B110","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.autrev.2017.03.010","article-title":"Bullous pemphigoid","volume":"16","author":"Bagci","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1172\/JCI28547","article-title":"T cell control in autoimmune bullous skin disorders","volume":"116","author":"Hertl","year":"2006","journal-title":"J Clin Invest"},{"key":"B112","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.clindermatol.2013.01.006","article-title":"Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies","volume":"31","author":"Lo Schiavo","year":"2013","journal-title":"Clin Dermatol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1038\/jid.2014.263","article-title":"Innate immune cell-produced IL-17 sustains inflammation in bullous pemphigoid","volume":"134","author":"Le Jan","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1111\/j.1600-0625.2011.01378.x","article-title":"Lesional Th17 cells and regulatory T cells in bullous pemphigoid","volume":"20","author":"Arakawa","year":"2011","journal-title":"Exp Dermatol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaut.2018.09.003","article-title":"IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid","volume":"96","author":"Chakievska","year":"2019","journal-title":"J Autoimmun"},{"key":"B116","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/ced.13135","article-title":"T regulatory cells and other lymphocyte subsets in patients with bullous pemphigoid","volume":"42","author":"Gambichler","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41598-018-19226-z","article-title":"Dysfunction of CD19+CD24hiCD27+ B regulatory cells in patients with bullous pemphigoid","volume":"8","author":"Liu","year":"2018","journal-title":"Sci Rep"},{"key":"B118","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.3389\/fimmu.2018.02687","article-title":"Complement-activating capacity of autoantibodies correlates with disease activity in bullous pemphigoid patients","volume":"9","author":"Chiorean","year":"2018","journal-title":"Front Immunol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3389\/fimmu.2018.00488","article-title":"Tissue destruction in bullous pemphigoid can be complement independent and may be mitigated by C5aR2","volume":"9","author":"Karsten","year":"2018","journal-title":"Front Immunol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2133.2008.08880.x","article-title":"Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications","volume":"160","author":"Marzano","year":"2009","journal-title":"Br J Dermatol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1365-2249.2009.03989.x","article-title":"Coagulation activation in autoimmune bullous diseases","volume":"158","author":"Marzano","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1586\/eci.09.40","article-title":"Activation of blood coagulation in autoimmune skin disorders","volume":"5","author":"Cugno","year":"2009","journal-title":"Exp Rev Clin Immunol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1365-2249.2011.04391.x","article-title":"Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases","volume":"165","author":"Marzano","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1111\/all.13131","article-title":"Evidence for a role of eosinophils in blister formation in bullous pemphigoid","volume":"72","author":"de Graauw","year":"2017","journal-title":"Allergy"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/bjd.16679","article-title":"Peripheral eosinophilia in bullous pemphigoid: prevalence and influence on the clinical manifestation","volume":"79","author":"Kridin","year":"2018","journal-title":"Br J Dermatol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1038\/s41598-017-04687-5","article-title":"Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome","volume":"7","author":"Giusti","year":"2017","journal-title":"Sci Rep"},{"key":"B127","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/jdv.12464","article-title":"Eosinophil cationic protein levels parallel coagulation activation in the blister fluid of patients with bullous pemphigoid","volume":"29","author":"Tedeschi","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1046\/j.1365-2133.2000.03599.x","article-title":"Elevated levels of eotaxin and interleukin-5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia","volume":"143","author":"Wakugawa","year":"2000","journal-title":"Br J Dermatol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1006\/cyto.2000.0791","article-title":"Bullous pemphigoid: interaction of interleukin 5, anti-basement membrane zone antibodies and eosinophils","volume":"13","author":"Engineer","year":"2001","journal-title":"Cytokine"},{"key":"B130","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1365-2249.2004.02570.x","article-title":"Interleukin-16 expression and release in bullous pemphigoid","volume":"137","author":"Frezzolini","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fmed.2018.00201","article-title":"The role of eosinophils in bullous pemphigoid: a developing model of eosinophil pathogenicity in mucocutaneous disease","volume":"5","author":"Amber","year":"2018","journal-title":"Front Med."},{"key":"B132","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/path.1674","article-title":"Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid","volume":"204","author":"Shimanovich","year":"2004","journal-title":"J Pathol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1172\/JCI117196","article-title":"92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen","volume":"93","author":"St\u00e5hle-B\u00e4ckdahl","year":"1994","journal-title":"J Clin Invest"},{"key":"B134","first-page":"897","article-title":"Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid","volume":"148","author":"Borrego","year":"1996","journal-title":"Am J Pathol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.jaci.2003.08.028","article-title":"Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization","volume":"112","author":"Davis","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jid.2017.11.031","article-title":"Eosinophils mediate tissue injury in autoimmune skin disease bullous pemphigoid","volume":"138","author":"Lin","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1684\/ejd.2018.3366","article-title":"Immunoglobulin E and bullous pemphigoid","volume":"28","author":"Cozzani","year":"2018","journal-title":"Eur J Dermatol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"e107725","DOI":"10.1371\/journal.pone.0107725","article-title":"Human eosinophils express the high affinity IgE receptor, Fc\u03b5RI, in bullous pemphigoid","volume":"9","author":"Messingham","year":"2014","journal-title":"PLoS ONE"},{"key":"B139","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.clim.2018.12.015","article-title":"IgE blockade in autoimmunity: omalizumab induced remission of bullous pemphigoid","volume":"198","author":"James","year":"2018","journal-title":"Clin Immunol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s40257-018-0401-6","article-title":"Rituximab and omalizumab for the treatment of bullous pemphigoid: a systematic review of the literature","volume":"2018","author":"Kremer","year":"2018","journal-title":"Am J Clin Dermatol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"766","DOI":"10.2340\/00015555-2951","article-title":"Eosinophils are a major source of interleukin-31 in bullous pemphigoid","volume":"98","author":"Rudrich","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1038\/jid.2015.106","article-title":"IL-31 induces chemotaxis, calciummobilization, release of reactive oxygen species, and CCL26 in eosinophils, which are capable to release IL-31","volume":"135","author":"Kunsleben","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jdermsci.2017.04.008","article-title":"Serum levels and tissue expression of interleukin-31 in dermatitis herpetiformis and bullous pemphigoid","volume":"87","author":"Bonciani","year":"2017","journal-title":"J Dermatol Sci"},{"key":"B144","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jdermsci.2017.07.019","article-title":"Elevated IL-31 serum levels in bullous pemphigoid patients correlate with eosinophil numbers and are associated with BP180-IgE","volume":"87","author":"Salz","year":"2017","journal-title":"J Dermatol Sci"},{"key":"B145","doi-asserted-by":"publisher","first-page":"870428","DOI":"10.1155\/2015\/870428","article-title":"Tissue factor in dermatitis herpetiformis and bullous pemphigoid: link between immune and coagulation system in subepidermal autoimmune bullous diseases","volume":"2015","author":"Zebrowska","year":"2015","journal-title":"Mediat Inflamm"},{"key":"B146","first-page":"71","article-title":"Disturbances of the expression of metalloproteinases and their tissue inhibitors cause destruction of the basement membrane in pemphigoid","volume":"57","author":"Narbutt","year":"2006","journal-title":"Pol J Pathol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1111\/j.1538-7836.2003.00462.x","article-title":"Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathways","volume":"1","author":"So","year":"2003","journal-title":"J Thromb Haemost"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.2169\/internalmedicine.46.0237","article-title":"Activations of coagulation and fibrinolysis secondary to bowel inflammation in patients with ulcerative colitis","volume":"46","author":"Kume","year":"2007","journal-title":"Intern Med"},{"key":"B149","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1182\/blood-2004-03-1203","article-title":"Patients with severe sepsis vary markedly in their ability to generate activated protein C","volume":"104","author":"Liaw","year":"2004","journal-title":"Blood"},{"key":"B150","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/jcp.1041280115","article-title":"Thrombin-induced increase in albumin permeability across the endothelium","volume":"128","author":"Garcia","year":"1986","journal-title":"J Cell Physiol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1152\/jappl.1990.69.5.1599","article-title":"Thrombin's enzymatic activity increases permeability of endothelial cell monolayers","volume":"69","author":"DeMichele","year":"1990","journal-title":"J Appl Physiol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1111\/j.1538-7836.2006.01970.x","article-title":"Antibodies to tissue-type plasminogen activator (t-PA) in patients with inflammatory bowel disease: high prevalence, interactions with functional domains of t-PA and possible implications in thrombosis","volume":"4","author":"Saibeni","year":"2006","journal-title":"J Thromb Haemost"},{"key":"B153","first-page":"254","article-title":"Anti-tumor necrosis factor alpha therapy normalizes fibrinolysis impairment in patients with active rheumatoid arthritis","volume":"28","author":"Ingegnoli","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1365-2249.2012.04674.x","article-title":"Prothrombotic state and impaired fibrinolysis in bullous pemphigoid, the most frequent autoimmune blistering disease","volume":"171","author":"Marzano","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"B155","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1161\/STROKEAHA.110.596361","article-title":"Increased risk of stroke in patients with bullous pemphigoid: a population-based follow-up study","volume":"42","author":"Yang","year":"2011","journal-title":"Stroke"},{"key":"B156","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1001\/archderm.141.6.691","article-title":"Prediction of survival for patients with bullous pemphigoid: a prospective study","volume":"141","author":"Joly","year":"2005","journal-title":"Arch Dermatol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1538-7836.2007.02489.x","article-title":"Venous thrombosis in the elderly","volume":"5","author":"Rosendaal","year":"2007","journal-title":"J Thromb Haemost"},{"key":"B158","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/j.1365-2133.2009.09350.x","article-title":"A population-based study of acute medical conditions associated with bullous pemphigoid","volume":"161","author":"Langan","year":"2009","journal-title":"Br J Dermatol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1160\/TH15-04-0309","article-title":"Increased risk of venous thromboembolism in patients with bullous pemphigoid","volume":"115","author":"Cugno","year":"2016","journal-title":"Thromb Haemost"},{"key":"B160","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2340\/00015555-1925","article-title":"A retrospective consecutive case-series study on the effect of systemic treatment, length of admission time, and co-morbidities in 98 bullous pemphigoid patients admitted to a tertiary centre","volume":"95","author":"Kibsgaard","year":"2015","journal-title":"Acta Derm Venereol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01407\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T16:38:21Z","timestamp":1694968701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01407\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,20]]},"references-count":160,"alternative-id":["10.3389\/fimmu.2019.01407"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01407","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,20]]},"article-number":"1407"}}